Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

123
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
123
Viral Mutations00:36

Viral Mutations

33.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shifts in Pediatric Respiratory Virus Trends After the COVID-19 Pandemic: Insights From a 12-Year Hospital-Based Study in South Korea.

International journal of pediatrics·2026
Same authorSame journal

Prevalence of Immediate-Type Food Allergy and Food-Induced Anaphylaxis in Korean Schoolchildren.

Allergy, asthma & immunology research·2026
Same author

The association of newborn metabolites with early-life wheezing and asthma among US children in the ECHO Program.

Communications medicine·2026
Same author

Multicohort analysis unveils axon guidance pathways linking small for gestational age to spirometric restriction.

Nature communications·2026
Same author

Optimized Propagation and Purification Protocols for Large-Scale Production of Rhinovirus C.

Viruses·2026
Same author

Association of Maternal Smoking During Pregnancy With Childhood Blood Pressure and Hypertension in the ECHO Cohort.

Circulation·2026

Related Experiment Video

Updated: Sep 13, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.2K

Clinical Significance of Rhinoviruses and Progress Toward Vaccination.

Eun Lee1, James E Gern2

  • 1Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea. unelee@daum.net.

Allergy, Asthma & Immunology Research
|July 30, 2025
PubMed
Summary

Rhinovirus (RV) vaccines are progressing due to new discoveries in conserved epitopes, offering hope against widespread respiratory infections. These advancements may soon provide a viable strategy to reduce the global health burden of RVs.

Keywords:
Asthmarespiratory tract infectionrhinovirusvaccinevulnerable populations

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K
Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
09:02

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on: September 22, 2023

1.6K

Related Experiment Videos

Last Updated: Sep 13, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.2K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K
Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
09:02

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on: September 22, 2023

1.6K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Rhinoviruses (RVs) are the leading cause of viral respiratory infections globally.
  • RVs contribute significantly to wheezing, asthma, and lower respiratory tract illnesses across all age groups.
  • Decades of vaccine development have been challenged by RVs' extensive serotypic diversity and weak cross-reactive immunity.

Purpose of the Study:

  • To review the current epidemiology of RV infections.
  • To discuss risk stratification for prioritizing vaccine development.
  • To summarize evolving RV vaccine development strategies and identify critical research gaps.

Main Methods:

  • Review of recent progress in structural virology and immune profiling.
  • Analysis of antigen discovery techniques, including peptide array mapping.
  • Evaluation of novel vaccine strategies targeting conserved epitopes and high-valent formulations.

Main Results:

  • Recent advances have identified conserved neutralizing epitopes on RVs.
  • Novel vaccine strategies targeting conserved B cell and T cell epitopes show promise in preclinical models.
  • Progress in understanding RV epidemiology and immune responses is accelerating vaccine development.

Conclusions:

  • Despite historical challenges, renewed interest and scientific momentum are driving RV vaccine development.
  • Targeting conserved epitopes and employing advanced formulation strategies are key to overcoming RV diversity.
  • RV vaccination holds potential as a future public health strategy to mitigate the global burden of RV-associated diseases.